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1. Introduction
  Radiotherapy is one of the main methods for treating gastric 
cancer, but the radiosensitivity varies in person. Inducing 
tumor cell apoptosis is one of the main mechanisms of 
radiotherapy, however, cell apoptosis was regulated by its 
related genes. Therefore, regarding apoptosis associated 
genes as the marker of radiosensitization has become the 
hot research spot[1]. Bcl-2, an important gene inhibiting 
apoptosis, plays an important role in maintaining cell 
proliferation, development and dynamic balance. The 
high expression of Bcl-2 gene can influence the tumor 
development in a certain degree and resist radiotherapy. 
Some researches[2-4] showed that the overexpression of 
Bcl-2 gene can inhibit tumor cell apoptosis induced by 
radiotherapy, and the inhibition of Bcl-2 gene expression 
may increase the radiosensitization to radiotherapy. 
RNA interference (RNAi) is the new discovered and 
developed gene block technique, inhibiting the expression 
of the target gene through using double strand RNA to 
induce the degradation of host homologous mRNA[5,6]. This 
research used synthesized siRNA to transfect gastric cancer 
BGC823 cells and observed the influence of inhibiting Bcl-2 
gene expression on the apoptosis and radiosensitivity, 
which provided theoretical basis for exploring the gene 
therapy for gastric cancer. 
2. Materials and methods 
2.1. Cell line and main reagents
  The human gastric cancer BGC823 cells were purchased 
from Shanghai Insitute of Biochemistry and Cell Biology, 
Academia Sinica. RPMI-1640 culture fluid and fetal bovine 
serum were from America Gibco Company; siRNA order, 
siRNA transfection reagent and siRNA culture fluid from 
America Qiagen Company. Lipo-fectamineTM 2000 liposome 
was the product of Santa Cruz Company. Mouse anti-human 
monoclonal antibody and HRP marked goat anti-rat second 
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antibody were purchased from Santa Cruz Company. All the 
primers were designed by the America Applied Biosystem 
Company and purchased from the Shanghai Boya Biology 
Co., Ltd. Annexin V-FITC apoptosis kits were from Beijing 
Baosai Biotech Co., Ltd.  
2.2. Design and synthesis of siRNA
  P o s i t i v e - s e n s e  s t r a n d  o f  B c l - 2  s i R N A :  5 ’ -
CGGCCUCUGUUUGAUUUCU- TT-3’; antisense strand: 5’-
AGAAAUCAAACAGAGGCCGTT-3. The negative control was 
siRNA aimed at no target gene, the positive-sense strand 
of which: 5’-UUCUCCGAACGUGUCACGUTT-3’; antisense 
strand: 5’-ACGUGACACGUUCGGAGAATT-3’. 
2.3. Cell culture and transfection
  Gastric cancer BGC823 cells were cultured in the RPMI1640 
culture fluid containing 10% fetal calf serum under the 
condition of 37 ℃, 5% CO2 and saturated humidity. One 
day before transfection, BGC823 cells in log phase were 
inoculated to 6-well culture plate at 5×105 cells/well. 24 h 
later when the cell was proliferated to 50%-70%, transfection 
was conducted according to the Lipo-fectamineTM 2000 
instruction. The transfection efficiency was detected by 
fluorescently-labeled siRNA. Three groups were control 
group: only liposome was added without any siRNA; 
negative control group: siRNA aimed at no target gene was 
transfected; Bcl-2 siRNA group: siRNA targeted at Bcl-2 
gene was transfected. 
2.4. Bcl-2 protein expression detected by Western blotting 
  The transfected cells were put in the cell lysis buffer. 
The protein concentration was detected by the Coomassie 
brilliant blue G-250 dying method. 10% SDS-PAGE 
electrophoresis was conducted. The products were 
electrotransferred to NC membrane. After washed by Tris 
buffer solution containing 2% BSA and sealed for 1 h, the first 
antibody-Bcl-2 mouse anti-human monoclonal antibody 
was added (The working fluid was diluted according to 1:10), 
then the second antibody- HRP marked goat anti-mouse 
IgG was added (The working fluid was diluted according to 
1:10). Then incubation was conducted for 1h at 37℃. DAB 
was used for coloration. 
2.5. Cell irradiation
  The cells were irradiated by 6MV X-ray produced by 
linear accelerator (dose rate: 4 Gy/min). The cell side of the 
culture flask was put upward with 1 cm compensator when 
conducting irradiation, and the ource-skin distance was 100 cm.  
2.6. Apoptosis detection
  After 48 h irradiation, the cells in 3 groups were washed 
twice by PBS and suspended in the 100 毺L AnnexinV 
binding buffer. Then the cell concentration was rejusted to 
1×106/mL by PBS. 10 毺L Annexin V-FITC and 5 毺L PI were 
added and well mixed. 15 min incubation was conducted 
at room temperature away from light. After adding 300 毺L 
combinding buffer, the cell apoptosis rate was detected by 
flow cytometry immediately. 
2.7. Clone forming assay
  After digesting the transfected and untransfected cells 
in log phase into single cell suspension, the cells were 
inoculated to 35mm corning culture dish according to 
150, 300, 600, 1 200, 1 500, 2 000 cells/dish. The cells were 
respectively given 0, 2, 4, 6, 8, 10 Gy X-ray irradiation 
after 24h culture. The cells were continuously given 10-
14 d conventional culture after irradiation. After Giemsa’s 
staining, the clone number of cells was counted by naked 
eye.
2.8. Statistical processing
  SPSS15.0 software was used for statistical processing. 
The measurement data were expressed by mean依standard 
deviation ( x依s). t test or single factor analysis of variance 
were adopted. A P<0.05 was taken to indicate a difference of 
statistical significance.
3. Results
3.1. Cell transfection of siRNA 
  siRNA was successfully transferred into gastric cancer 
BGC823 cell. The transfected BGC823 cell can be seen in 
green fluorescence under the fluorescent microscope. Cell in 
the shape of polygon was successfully transfected (Figure 1).
The transfection efficacy was highest (92%) when the final 
concentration of siRNA was 100 nM.
 
Figure 1. Fluorescent microscope image (×200) and inverted 
microscope image (×100) of siRNA transfected gastric cancer BGC823 
cell. 
3.2. Expression change of Bcl-2 protein after siRNA 
transfection 
  The Bcl-2 protein expression in BGC823 cell detected 
by Western-Blotting indicated that the Bcl-2/毬-action 
expression level of the control group, negative control group 
and Bcl-2 siRNA group was 85.41依1.63, 82.68依3.74 and 
35.45依2.35. There was no statistical significance between 
the former two groups (t=1.03, P >0.05). There was statistical 
significance when comparing the Bcl-2 siRNA group 
with the other two groups (t=24.53, t=18.52, P<0.01). This 
indicated that siRNA targeted interference can significantly 
inhibit the expression level of the Bcl-2 protein. 
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3.3. Change of cell apoptosis rate before and after the X-ray 
irradiation 
  Before X-ray irradiation, the apoptosis rate of the BGC823-
RNAi cell group was (10.81依0.91)% which was significantly 
increased comparing with the BGC823 cell group and the 
BGC823-Neg cell group (t=8.09, t=7.21, P <0.01). After 48 h 
X-ray irradiation, the apoptosis rate of the BGC823-RNAi 
cell group reached (28.91依1.40)%, and there was statistical 
significance comparing with the other two groups after 
irradiation (t=9.76, t=8.64, P <0.01). The apoptosis rate of 
the BGC823-RNAi cell group after irradiation was obviously 
increased comparing with that before irradiation (t=18.78, 
P <0.01). All these indicated that Bcl-2 siRNA can promote 
BGC823 cell apoptosis and improve the cell’s radiosensitivity 
(Table 1, Figure 2). 
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Figure 2. BGC823 cell apoptosis of Bcl-2 siRNA transfection 
combined with X-ray irradiation. 
A: Simple X-ray group.
B: Negative siRNA transfection +X-ray group.
C: Bcl-2 siRNA1 transfection +X-ray group.
3.4. Analysis of the cell clone formation 
  The cell survival curve after Bcl-2 siRNA1 combined with 
X-ray irradiation at different doses showed that the cell 
survival curve obviously decreased in Bcl-2 siRNA1 group, 
while the cell survival curve in negative siRNA transfection 
group decreased unobviously (Figure 3). Radiobiological 
parameters were in Table 2 and SER was 1.28 (ratio of 
D0), 1.60 (ratio of Dq), which indicated that there was 
certain radiosensitivity effect after the BGC823 cells were 
transfected by Bcl-2 siRNA.
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Figure 3. Influence of Bcl-2 siRNA transfection combined with 
X-ray irradiation on the cell survival curve.
4. Discussion 
  RNAi, a new technique developed in recent years having 
the characteristics of high degree of specificity and 
efficiency, is a silencing course after the transcription 
of specific homologous target gene induced by double-
strand RNA. In the cells, siRNA distinguishes and combines 
the corresponding target mRNA strand through base 
complementrity, leading nuclease to cutting and digesting 
this mRNA strand. Finally, it leads to the silencing of target 
gene after transcription[7,8]. The recent studies showed 
that RNAi was widely used in experimental study as a 
regulation or close gene expression tool[9]. The researchers 
have successfully decreased the expression of many kinds 
of molecules in tumor cells by using RNAi technique. This 
research successfully decreased Bcl-2 protein expression in 
gastric cancer BGC823 cells, which verified the efficacy of 
RNA interference again.
  Bcl-2 gene, a kind of apoptosis inhibition gene which 
has been studied lucidly so far, plays a key role in 
inducing apoptosis[10]. Bcl-2 protein prevents the release 
of cytochrome C from chondriosome through regulating 
endoplasmic reticulum Ca2+-involved intranuclear and 
extranuclear matter translocation and permeability 
transition (PT). Furthermore, Bcl-2 interacts with Apaf-1, 
procaspase-9. Finally, it inhibits the apoptosis cascade 
reaction process caused by Caspase-9 and Caspase-3. 
Table 1
Change of cell apoptosis before and after X-ray irradiation ( x依s, n=3).
BGC823 (%) BGC823-Neg (%) BGC823-RNAi (%)
Before radiation   5.30依0.75   5.82依0.78 10.81依0.91
Afrer radiation 18.95依1.08 19.48依1.27 28.91依1.40
Note: Compared with before radiation, P＜0.01; Compared with BGC823, △P＜0.01; Compared with BGC823-Neg, ▲P＜0.01
Table 2
Radiobiological parameters of BGC823 cell multitarget simple hit model after fitting. 
Group D0 Dq SF2
Control group 1.92 1.33 0.62
Negative siRNA transfection group 1.91 1.15 0.52
Bcl-2 siRNA transfection group 1.50 0.83 0.38
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Besides, Bcl-2 can inhibit the activation of many caspase 
hydratase molecules, which finally prevents the occurrence 
of apoptosis[11-13]. Studies indicated that many tumors high 
express Bcl-2 protein[14-16], including gastric cancer. And 
Bcl-2 protein is related to the repellence of tumor cells to 
chemotherapy and radiotherapy[17-19]. It is a good target of 
anti-tumor molecule. Currently, many experimental studies 
on Bcl-2 have been reported in domestic and abroad. 
These experimental studies have certain positive effect on 
increasing radiation sensitivity of tumor and improving 
apoptosis rate of tumor cells. Yang et al[20] used adenovirus 
mediated siRNA to inhibit Bcl-2 protein expression in colon 
cancer cell, which significantly increases the radiation 
sensitivity of colon cancer cells. Kim et al[21] reported that 
using RNA to interfere Bcl-2 gene expression can inhibit 
the proliferation of tumor carneus cell line. The studies of 
Hara et al[22] verified that Bcl-2 antisense oligonucleotides 
can combine with the target DNA or mRNA in cells and 
prevent its transcription or translation process. As a result, 
it can inhibit Bcl-2 protein expression. In this study, 
the Bcl-2 specific siRNA was induced into BGC823 cells 
through liposome transfection technique, which successfully 
decreased Bcl-2 protein expression and induced the 
apoptosis of BGC823 cells.
  This research showed that compared with the control 
group and the negative siRNA transfection group, after the 
transfection of Bcl-2 siRNA, the sensitivity of BGC823 cells 
to X-ray irradiation obviously increased (P<0.01), apoptosis 
and death rate significantly increased, the clone forming rate 
significantly decreased and the cell survival curve obviously 
declined, the radiosensitization ratio was 1.28 (ratio of the 
D0 value) and 1.60 (ratio of the Dq value). It is believed that 
after BGC823 cells are transfected by siRNA, Bcl-2 protein 
expression in cells decreases and the threshold value of 
cells to apoptosis signals significantly decreases. When the 
apoptosis signal is given to X-ray irradiation, the death rate 
of cells significantly increases. Because simple Bcl-2 siRNA 
interference has increased apoptosis, the death of tumor 
cells is increased to a greater degree when it combines 
X-ray irradiation. Therefore, the tumor inhibition rate is 
increased. 
  The results of this study showed that using RNAi technique 
can decrease Bcl-2 protein expression in gastric cancer 
cell- BGC823 and the sensitivity of gastric cancer cell 
to X-ray irradiation was significantly increased, which 
provided a certain theoretical basis for the application of 
Bcl-2 gene specific siRNA in clinical treatment of gastric 
cancer.
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